It is found in every cell in the body and is made from three amino acids - glycine, cysteine and glutamic acid
For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatrutide research peptide, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways
It covers all four common concentrations in one place
Hypoglycemia in insulin-treated diabetes: a case for increased vigilance
While those results are encouraging, direct comparisons between Retatrutide and tirzepatide should be interpreted carefully because the medications have been studied in different clinical trials with different patient populations, treatment durations, and study designs